Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells

Deshanie Rai, Antonina Frolova, Jonna Frasor, Anne E. Carpenter, Benita S. Katzenellenbogen

Research output: Contribution to journalArticle

Abstract

Estrogens regulate multiple activities in breast cancer cells, including proliferation. Whereas these hormones are most commonly known to regulate gene transcription through direct interaction with estrogen receptors (ERs) and with specific DNA sequences of target genes, recent studies show that ER also activates a number of rapid signaling events that are initiated at the cell membrane. To study the membrane-initiated effects of estrogen and separate them from the activities initiated by the nuclear localized ER in human breast cancer cells, we generated MDA-MB-231 breast cancer cell lines that have stably integrated either the wild-type nuclear form of ER (WT-ER) or a modified, membrane-targeted ER (MT-ER) that lacks a nuclear localization sequence and is dually acylated with a myristoylation sequence at the N terminus and a palmitoylation sequence at the C terminus. We demonstrate that MT-ER is membrane localized in the absence of estradiol (E2), showing punctate membrane and cytoplasmic speckles after E2 exposure. In contrast to WT-ER, MT-ER was not down-regulated by E2 or by antiestrogen ICI 182,780 exposure, and MT-ER failed to regulate endogenous E2-responsive genes highly up-regulated by WT-ER. Cells expressing MT-ER showed a greater serum response element-mediated transcriptional response that was partially inhibited by antiestrogen ICI 182,780. The MT-ER and WT-ER differentially altered ERK1/2 and Akt activities and the proliferation of breast cancer cells in response to E2. Hence, this study reveals distinct actions of the MT-ER vs. the WT-ER in effecting estrogen actions in breast cancer cells.

Original languageEnglish (US)
Pages (from-to)1606-1617
Number of pages12
JournalMolecular Endocrinology
Volume19
Issue number6
DOIs
StatePublished - Jun 1 2005

Fingerprint

Estrogen Receptors
Breast Neoplasms
Membranes
Estrogens
Estrogen Receptor Modulators
Cell Membrane
Serum Response Element
Lipoylation
Genes
Estradiol
Cell Proliferation
Hormones
Cell Line

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology

Cite this

Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells. / Rai, Deshanie; Frolova, Antonina; Frasor, Jonna; Carpenter, Anne E.; Katzenellenbogen, Benita S.

In: Molecular Endocrinology, Vol. 19, No. 6, 01.06.2005, p. 1606-1617.

Research output: Contribution to journalArticle

Rai, Deshanie ; Frolova, Antonina ; Frasor, Jonna ; Carpenter, Anne E. ; Katzenellenbogen, Benita S. / Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells. In: Molecular Endocrinology. 2005 ; Vol. 19, No. 6. pp. 1606-1617.
@article{091a53c1a42f483abb93a660934dcb25,
title = "Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells",
abstract = "Estrogens regulate multiple activities in breast cancer cells, including proliferation. Whereas these hormones are most commonly known to regulate gene transcription through direct interaction with estrogen receptors (ERs) and with specific DNA sequences of target genes, recent studies show that ER also activates a number of rapid signaling events that are initiated at the cell membrane. To study the membrane-initiated effects of estrogen and separate them from the activities initiated by the nuclear localized ER in human breast cancer cells, we generated MDA-MB-231 breast cancer cell lines that have stably integrated either the wild-type nuclear form of ER (WT-ER) or a modified, membrane-targeted ER (MT-ER) that lacks a nuclear localization sequence and is dually acylated with a myristoylation sequence at the N terminus and a palmitoylation sequence at the C terminus. We demonstrate that MT-ER is membrane localized in the absence of estradiol (E2), showing punctate membrane and cytoplasmic speckles after E2 exposure. In contrast to WT-ER, MT-ER was not down-regulated by E2 or by antiestrogen ICI 182,780 exposure, and MT-ER failed to regulate endogenous E2-responsive genes highly up-regulated by WT-ER. Cells expressing MT-ER showed a greater serum response element-mediated transcriptional response that was partially inhibited by antiestrogen ICI 182,780. The MT-ER and WT-ER differentially altered ERK1/2 and Akt activities and the proliferation of breast cancer cells in response to E2. Hence, this study reveals distinct actions of the MT-ER vs. the WT-ER in effecting estrogen actions in breast cancer cells.",
author = "Deshanie Rai and Antonina Frolova and Jonna Frasor and Carpenter, {Anne E.} and Katzenellenbogen, {Benita S.}",
year = "2005",
month = "6",
day = "1",
doi = "10.1210/me.2004-0468",
language = "English (US)",
volume = "19",
pages = "1606--1617",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells

AU - Rai, Deshanie

AU - Frolova, Antonina

AU - Frasor, Jonna

AU - Carpenter, Anne E.

AU - Katzenellenbogen, Benita S.

PY - 2005/6/1

Y1 - 2005/6/1

N2 - Estrogens regulate multiple activities in breast cancer cells, including proliferation. Whereas these hormones are most commonly known to regulate gene transcription through direct interaction with estrogen receptors (ERs) and with specific DNA sequences of target genes, recent studies show that ER also activates a number of rapid signaling events that are initiated at the cell membrane. To study the membrane-initiated effects of estrogen and separate them from the activities initiated by the nuclear localized ER in human breast cancer cells, we generated MDA-MB-231 breast cancer cell lines that have stably integrated either the wild-type nuclear form of ER (WT-ER) or a modified, membrane-targeted ER (MT-ER) that lacks a nuclear localization sequence and is dually acylated with a myristoylation sequence at the N terminus and a palmitoylation sequence at the C terminus. We demonstrate that MT-ER is membrane localized in the absence of estradiol (E2), showing punctate membrane and cytoplasmic speckles after E2 exposure. In contrast to WT-ER, MT-ER was not down-regulated by E2 or by antiestrogen ICI 182,780 exposure, and MT-ER failed to regulate endogenous E2-responsive genes highly up-regulated by WT-ER. Cells expressing MT-ER showed a greater serum response element-mediated transcriptional response that was partially inhibited by antiestrogen ICI 182,780. The MT-ER and WT-ER differentially altered ERK1/2 and Akt activities and the proliferation of breast cancer cells in response to E2. Hence, this study reveals distinct actions of the MT-ER vs. the WT-ER in effecting estrogen actions in breast cancer cells.

AB - Estrogens regulate multiple activities in breast cancer cells, including proliferation. Whereas these hormones are most commonly known to regulate gene transcription through direct interaction with estrogen receptors (ERs) and with specific DNA sequences of target genes, recent studies show that ER also activates a number of rapid signaling events that are initiated at the cell membrane. To study the membrane-initiated effects of estrogen and separate them from the activities initiated by the nuclear localized ER in human breast cancer cells, we generated MDA-MB-231 breast cancer cell lines that have stably integrated either the wild-type nuclear form of ER (WT-ER) or a modified, membrane-targeted ER (MT-ER) that lacks a nuclear localization sequence and is dually acylated with a myristoylation sequence at the N terminus and a palmitoylation sequence at the C terminus. We demonstrate that MT-ER is membrane localized in the absence of estradiol (E2), showing punctate membrane and cytoplasmic speckles after E2 exposure. In contrast to WT-ER, MT-ER was not down-regulated by E2 or by antiestrogen ICI 182,780 exposure, and MT-ER failed to regulate endogenous E2-responsive genes highly up-regulated by WT-ER. Cells expressing MT-ER showed a greater serum response element-mediated transcriptional response that was partially inhibited by antiestrogen ICI 182,780. The MT-ER and WT-ER differentially altered ERK1/2 and Akt activities and the proliferation of breast cancer cells in response to E2. Hence, this study reveals distinct actions of the MT-ER vs. the WT-ER in effecting estrogen actions in breast cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=22344449234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22344449234&partnerID=8YFLogxK

U2 - 10.1210/me.2004-0468

DO - 10.1210/me.2004-0468

M3 - Article

C2 - 15831524

AN - SCOPUS:22344449234

VL - 19

SP - 1606

EP - 1617

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 6

ER -